Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Appointed director
|
|
Skye Bioscience, Inc. (NMUS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/22/2018 |
8-K
| Resignation/termination of a director|
Docs:
|
"Form of Restricted Stock Agreement, by and between Nemus Bioscience, Inc. and the Restricted Stockholders party thereto",
"Securities Purchase Agreement, by and among Nemus Bioscience, Inc., Nemus and Emerald Health Sciences Inc",
"Nemus Secures Emerald Health as Strategic Majority Investor to help Advance Clinical Development of Novel Cannabinoid-based Therapeutics Nemus Bioscience Receives $400,000 Funding under Convertible Bridge Loan and Closes Initial $1,500,000 Private Placement" |
|
|
|